Cogent Biosciences, Inc. (COGT) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2016: -$24.70M2017: -$48.85M2018: $60.23M2019: $31.76M2020: $234.67M2021: $214.18M2022: $255.74M2023: $257.80M2024: $256.29M2025: $636.37M$636.37M
2016Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$636.37M+148.3%
2024$256.29M-0.6%
2023$257.80M+0.8%
2022$255.74M+19.4%
2021$214.18M-8.7%
2020$234.67M+638.8%
2019$31.76M-47.3%
2018$60.23M+223.3%
2017-$48.85M-97.8%
2016-$24.70M